Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Lantus (insulin glargine) and Apidra (insulin glulisine) are both insulins used to manage blood sugar levels in people with diabetes, but they have some key differences. Lantus is a long-acting insulin that is typically injected once daily and helps control blood sugar levels for about 24 hours. In contrast, Apidra is a rapid-acting insulin that starts working within 15 minutes and is usually taken before or right after meals to manage blood sugar spikes. Lantus is used for both Type 1 and Type 2 diabetes in adults and children, while Apidra is used for Type 1 diabetes in children aged 4 and older and for Type 2 diabetes in adults. Apidra can also be administered through an insulin pump or an IV injection in a hospital setting, whereas Lantus is only given as a subcutaneous injection. Both medications can cause low blood sugar and weight gain, but Apidra needs to be taken multiple times a day, which might be less convenient than the once-daily dosing of Lantus.
Insulin glulisine is a rapid-acting insulin that's available as a vial (Apidra) and a pre-filled pen (Apidra Solostar). It's used to control blood sugar from meals for people with either Type 1 diabetes (T1D) or Type 2 diabetes (T2D). Apidra (insulin glulisine) is given under the skin as either a quick injection or continuously through an insulin pump. It can also be given as an injection through the veins (IV) for people in the hospital. Side effects include low blood sugar (hypoglycemia) and common cold symptoms.